Research Database

11 studies found

Positive

45.5%

Negative

9.1%

Inconclusive

45.5%

Page 1 of 1

PositiveReview/Other

Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome

2024

Polycystic Ovary Disease

InconclusiveReview/Other

Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes

2022

Polycystic Ovary Disease

InconclusiveReview/Other

Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome

2017

Polycystic Ovary Disease

InconclusiveReview/Other

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

2017

Polycystic Ovary Disease

PositiveClinical Trial

Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin

2017

Polycystic Ovary Disease

PositiveReview/Other

Decreased Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome

2016

Polycystic Ovary Disease

PositiveReview/Other

Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome

2016

Obesity

PositiveReview/Other

Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome

2015

Polycystic Ovary Disease

NegativeReview/Other

Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome

2015

Polycystic Ovary Disease

InconclusiveReview/Other

The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome

2014

Diabetes

InconclusiveReview/Other

Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls

2014

Fatty Liver Disease

Command Palette

Research Database

Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome

Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes

Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin

Decreased Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome

Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome

Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome

Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome

The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome

Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls